NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 203 filers reported holding NEVRO CORP in Q2 2017. The put-call ratio across all filers is 1.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $5,548,000 | -13.1% | 85,577 | -16.2% | 0.51% | -10.5% |
| Q1 2019 | $6,385,000 | +42.5% | 102,149 | -11.4% | 0.57% | +18.0% |
| Q4 2018 | $4,482,000 | +161.3% | 115,257 | +482.3% | 0.48% | +291.9% |
| Q1 2018 | $1,715,000 | -17.8% | 19,793 | -34.5% | 0.12% | +78.3% |
| Q4 2017 | $2,086,000 | +4.2% | 30,200 | +37.2% | 0.07% | -50.0% |
| Q3 2017 | $2,001,000 | +6.0% | 22,016 | -13.2% | 0.14% | +3.8% |
| Q2 2017 | $1,888,000 | -26.6% | 25,360 | -7.7% | 0.13% | -26.5% |
| Q1 2017 | $2,572,000 | -64.2% | 27,462 | -60.1% | 0.18% | -62.1% |
| Q3 2016 | $7,185,000 | +40.6% | 68,827 | -0.7% | 0.48% | +34.6% |
| Q2 2016 | $5,111,000 | +124.3% | 69,292 | +71.1% | 0.36% | +112.6% |
| Q1 2016 | $2,279,000 | – | 40,500 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
| Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
| PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
| Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
| Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
| Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
| K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
| Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
| Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
| ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |